Evidence map›Paper›PMID 19933732›Full record

ArticlePediatrics2009

Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.

Grace M Aldrovandi, Clara Chu, William T Shearer, Daner Li, Jan Walter, Bruce Thompson, Kenneth McIntosh, Marc Foca, William A Meyer, Belinda F Ha and 2 more

Abstract read
In one paragraph

Article in Pediatrics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 2 pooled it
2.7field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 2 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Observational
  5. Frontiers in neuroscience · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Mitochondrial toxicity and caspase activation in HIV pregnant women.Journal of cellular and molecular medicine · 2017
    Observational
  19. Complications of Treatment in Youth with HIV.Current HIV/AIDS reports · 2016
    Review
  20. DisclosingJournal of the International AIDS Society · 2016
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 1 country.

Grace M AldrovandiSaban Research Institute of Childrens Hospital Los Angeles, University of Southern California, Los Angeles, California 90027, USA. galdrovandi@chla.usc.edu
Clara Chu
William T Shearer
Daner Li
Jan Walter
Bruce Thompson
Kenneth McIntosh
Marc Foca
William A Meyer
Belinda F Ha
Kenneth C Rich
Jack Moye
Clinical Trials and Surveys Corporation · USBaylor College of Medicine · USCenter for Children · USChildren's Hospital of Los Angeles · USColumbia University · USHarvard University Press · USQuest Diagnostics (United States) · USResearch Triangle Park Foundation · USUniversity of Illinois Chicago · USUniversity of Southern California · US

Funding

International Maternal Pediatric Adolescent AIDS Clinical Trials (IMPAACT) GroupU01AI068632 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI JACKSON, J BROOKS · 2006 to 2010
$109.7M
PEDIATRIC AIDS CLINICAL TRIALS GROUP--COORDINATE/OPERATEU01AI041089 · NIAID · SOCIAL AND SCIENTIFIC SYSTEMS, INC. · PI SPECTOR, STEPHEN A · 1997 to 2005
$71.9M
LC - IMPAACT Leadership GroupUM1AI106716 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Grace M Aldrovandi · 2014 to 2026
$47.2M
ZDV &3TC NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFECTED INFANTS &M01RR000865 · NCRR · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WASHINGTON, ARNOLD E. · 1985 to 2011
$43.4M
Statistical/Data Management Center-Pediatric AIDS CTGU01AI041110 · NIAID · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI FENTON, TERRENCE · 1997 to 2006
$38.6M
ZOLENDRONIC ACID IN CHILDREN W/ SEVERE OSTEOGENESIS IMPERFECTAM01RR000188 · NCRR · BAYLOR COLLEGE OF MEDICINE · PI SHEARER, WILLIAM THOMAS · 1985 to 2011
$30.6M
ZOLEDRONIC ACID IN PROSTATE CANCERM01RR000645 · NCRR · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI COLTEN, HARVEY R · 1985 to 2006
$27.0M
ZIDOVUDINE &LAMIVUDINE &NEVIRAPINE COMBINATION THERAPY IN HIV 1 INFM01RR001271 · NCRR · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KESSLER, DAVID A · 1985 to 2006
$22.7M
Virology CoreP30AI036211 · NIAID · BAYLOR COLLEGE OF MEDICINE · PI RICE, ANDREW P · 1994 to 2015
$21.7M
ZIDOVUDINE VS 2',3'DIDEHYDRO-3'DEOXYTHYMIDINE IN CHILDRENM01RR000240 · NCRR · CHILDREN'S HOSP OF PHILADELPHIA · PI ALTSCHULER, STEVEN M · 1985 to 2006
$15.3M
PEDIATRIC AND MATERNAL HIV CLINICAL TRIALS NETWORK-275933162N01HD033162 · NICHD · WESTAT, INC. · 1993 to 2003
$15.0M
PEDIATRIC AIDS CLINICAL TRIALS UNITU01AI027559 · NIAID · LURIE CHILDREN'S HOSPITAL OF CHICAGO · PI YOGEV, RAM · 1988 to 2006
$9.1M
NCRR NIH HHS K01 RR000188NCRR NIH HHS M01 RR000188NCRR NIH HHS M01 RR000240NCRR NIH HHS M01 RR000645NCRR NIH HHS M01 RR000865NCRR NIH HHS M01 RR001271NCRR NIH HHS M01 RR-00188NCRR NIH HHS M01 RR-00240NCRR NIH HHS M01 RR-00865NCRR NIH HHS M01 RR-01271NCRR NIH HHS RR00188NCRR NIH HHS RR00645NIAID NIH HHS N01 AI085339NIAID NIH HHS N01 AI 85339NIAID NIH HHS P30 AI036211NIAID NIH HHS P30 AI36211NIAID NIH HHS R01 AI94029NIAID NIH HHS U01 AI027541NIAID NIH HHS U01 AI027550NIAID NIH HHS U01 AI027551NIAID NIH HHS U01 AI027559NIAID NIH HHS U01 AI032907NIAID NIH HHS U01 AI032921NIAID NIH HHS U01 AI034841NIAID NIH HHS U01 AI034858NIAID NIH HHS U01 AI041089NIAID NIH HHS U01 AI041110NIAID NIH HHS U01 AI050274NIAID NIH HHS U01 AI068632NIAID NIH HHS U01 AI 27541NIAID NIH HHS U01 AI 27550NIAID NIH HHS U01 AI27551NIAID NIH HHS U01 AI27559NIAID NIH HHS U01 AI32907NIAID NIH HHS U01 AI32921NIAID NIH HHS U01 AI 34841NIAID NIH HHS U01 AI34858NIAID NIH HHS U01 AI41089NIAID NIH HHS U01 AI41110NIAID NIH HHS U01 AI 50274-01NIAID NIH HHS UM1 AI106716NICHD NIH HHS HD-3-6117NICHD NIH HHS N01 HD033162NICHD NIH HHS N01 HD33162NICHD NIH HHS R01 HD040777NICHD NIH HHS U01 HD041983NICHD NIH HHS U01 HD 41983NIDA NIH HHS 9U01 DA 15054NIDA NIH HHS U01 DA015053NIDA NIH HHS U01 DA015054NIDA NIH HHS U01 DA 15053
6 · The paper itself

Abstract

objectiveConcern for potential adverse effects of antiretroviral (ARV) chemotherapy used to prevent mother-to-child HIV transmission has led the US Public Health Service to recommend long-term follow-up of ARV-exposed children. Nucleoside reverse transcriptase inhibitor ARV agents can inhibit DNA polymerase gamma, impairing mitochondrial DNA (mtDNA) synthesis and resulting in depletion or dysfunction.

methodsWe measured the mtDNA content of stored peripheral blood mononuclear cells (PBMCs) of 411 healthy children who were born to HIV-uninfected women and 213 uninfected infants who were born to HIV-infected women with or without in utero and neonatal ARV exposure. Cryopreserved PBMC mtDNA was quantified by using the Primagen Retina Mitox assay.

resultsGeometric mean PBMC mtDNA levels were lower at birth in infants who were born to HIV-infected women. Among HIV-exposed children, mtDNA levels were lowest in those who were not exposed to ARVs, higher in those with exposure to zidovudine alone, and higher still in those with combination nucleoside reverse transcriptase inhibitor exposure. A similar pattern was observed in the corresponding women. Levels of mtDNA increased during the first 5 years of life in all HIV-exposed children but achieved normal levels only in those with ARV exposure.

conclusionsLevels of mtDNA are lower than normal in HIV-exposed children. Contrary to expectation, PBMC mtDNA levels are significantly higher in ARV-exposed, HIV-uninfected infants and their infected mothers compared with ARV-unexposed infants and women. By 5 years, levels of PBMC mtDNA rise to normal concentrations in ARV-exposed children but remain depressed in ARV-unexposed children.

Indexed as

HIV-1Anti-HIV AgentsDNA, MitochondrialDrug Therapy, CombinationFemaleHIV InfectionsHumansInfantInfant, NewbornInfectious Disease Transmission, VerticalLamivudineLongitudinal StudiesMonocytesPregnancyPregnancy Complications, InfectiousPregnancy Trimester, ThirdAnti-HIV AgentsDNA, MitochondrialLamivudineReverse Transcriptase InhibitorsZidovudine

Identifiers

PMID19933732
PMCPMC2904486
OpenAlexW2027372705

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.